The nutraceutical gummies market is projected to grow from USD 24.39 billion in 2025 to reach USD 47.80 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.4% during the forecast period. The global nutraceutical gummies market is witnessing significant growth driven by shifting consumer health priorities and evolving supplement consumption habits. Consumers across age groups are increasingly shifting from traditional tablets and capsules toward convenient, palatable, and easy-to-consume gummy formats. Rising awareness of preventive healthcare, immune support, digestive wellness, and daily nutritional supplementation is accelerating demand, particularly for vitamins, minerals, probiotics, and functional ingredients. In the B2C segment, gummies appeal strongly to children, adults, and aging populations due to improved taste, compliance, and portability. The B2B segment is driven by growing demand from nutraceutical brands, private-label players seeking differentiated delivery formats, and clean label formulations. Manufacturers are focusing on fortified formulations and reduced sugar content to meet regulatory standards and consumer expectations. Gummies serve both mass market wellness needs and specialized nutrition applications. They have emerged as a core dosage form within the nutraceutical industry, driving sustained demand across both B2B and B2C channels.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15848651
Asia Pacific is projected to be the fastest-growing region in the nutraceutical gummies market during the forecast period.
Asia Pacific is expected to be the fastest-growing region in the nutraceutical gummies market. This is due to the high burden of micronutrient deficiencies and the need for child-friendly supplementation formats. According to UNICEF, in East Asia and the Pacific, one in every two young children (around 52 million children under five years of age) suffers from at least one micronutrient deficiency. This highlights a significant nutrition gap across the region. This widespread deficiency creates strong demand for preventive nutrition solutions, where nutraceutical gummies offer an effective, palatable, and easy-to-administer option, especially for children who refuse to take traditional tablets or syrups.
Beyond pediatric nutrition, this micronutrient burden drives broader adoption of fortified supplements among adults, boosting B2C demand and simultaneously encouraging nutraceutical companies to scale production of convenient dosage forms. As gummies improve compliance and acceptance across age groups, manufacturers and contract formulators are increasingly focusing on the Asia Pacific region to address large unmet nutritional needs, positioning it as the fastest-growing market for nutraceutical gummies across both B2B and B2C channels.
The online sales channels segment is estimated to be the fastest-growing in the nutraceutical gummies market during the forecast period.
The online sales channels segment is expected to be the fastest-growing, driven by the rapid expansion of e-commerce platforms, rising digital health awareness, and consumer preference for convenient, direct-to-consumer purchasing. Easy access to product information, wider brand availability, subscription models, and doorstep delivery are accelerating online adoption across both B2C consumers and B2B buyers seeking faster procurement and broader product portfolios.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=15848651
The Gen Alpha (0–12 years) demographic segment is estimated to be the fastest-growing in the nutraceutical gummies market during the forecast period.
The Gen Alpha (0–12 years) demographic segment is estimated to be the fastest-growing in the market. This can be due to the high global burden of childhood micronutrient deficiencies and growing emphasis on early preventive nutrition. WHO recommendations underscore the importance of vitamin and mineral intake during childhood to support immunity, growth, and cognitive development, reinforcing sustained demand for pediatric supplements.
Gummy and chewable supplement formulations significantly improve compliance among children due to taste, texture, and ease of consumption. This supplement form strongly influences adherence compared to conventional dosage forms such as tablets and capsules. As parents increasingly prefer child-friendly, preventive nutrition solutions, nutraceutical gummies are gaining rapid acceptance among Gen Alpha, positioning this demographic as the fastest-growing consumer segment.
Leading Nutraceutical Gummies Companies:
The report profiles key players such as Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada). Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US), Activ’Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among others.
